Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease

Anna C. Riddell, Beatrix Kele, Kathryn Harris, Jon Bible, Maurice Murphy, Subathira Dakshina, Nathaniel Storey, Dola Owoyemi, Corinna Pade, Joseph M. Gibbons, David Harrington, Eliza Alexander, Áine McKnight, Teresa Cutino-Moguel
doi: https://doi.org/10.1101/2022.01.14.21267836
Anna C. Riddell
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anna.riddell1@nhs.net maria-teresa.cutino-moguel@nhs.net
Beatrix Kele
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Harris
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Bible
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurice Murphy
2Department of Infection and Immunity, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subathira Dakshina
2Department of Infection and Immunity, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel Storey
3Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dola Owoyemi
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinna Pade
4Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph M. Gibbons
4Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Harrington
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliza Alexander
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Áine McKnight
4Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Cutino-Moguel
1Virology Department, Division of Infection, Barts Health NHS Trust, London, E1 2ES, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anna.riddell1@nhs.net maria-teresa.cutino-moguel@nhs.net
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The emergence of new SARS-COV-2 variants is of public health concern in case of vaccine escape. Described are three patients with advanced HIV-1 and chronic SARS-CoV-2 infection in whom there is evidence of selection and persistence of novel mutations which are associated with increased transmissibility and immune escape.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The chair of the research governance committee of Barts Health NHS Trust and Queen Mary University of London has waived ethical approval for this work on behalf of the committee.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study which is not included in the manuscript and supplementary material are available upon reasonable request to the authors

http://cov-glue.cvr.gla.ac.uk/#/home

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 15, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
Anna C. Riddell, Beatrix Kele, Kathryn Harris, Jon Bible, Maurice Murphy, Subathira Dakshina, Nathaniel Storey, Dola Owoyemi, Corinna Pade, Joseph M. Gibbons, David Harrington, Eliza Alexander, Áine McKnight, Teresa Cutino-Moguel
medRxiv 2022.01.14.21267836; doi: https://doi.org/10.1101/2022.01.14.21267836
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease
Anna C. Riddell, Beatrix Kele, Kathryn Harris, Jon Bible, Maurice Murphy, Subathira Dakshina, Nathaniel Storey, Dola Owoyemi, Corinna Pade, Joseph M. Gibbons, David Harrington, Eliza Alexander, Áine McKnight, Teresa Cutino-Moguel
medRxiv 2022.01.14.21267836; doi: https://doi.org/10.1101/2022.01.14.21267836

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10299)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1768)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)